Skip to content

Mendel Kaelen

Imperial College London

44 papers in the library · 9,011 citations · publishing 2013-2026

Papers

Sort Most recent Most cited

Effects of psychedelic use on authoritarian attitudes revisited.

Journal of Psychopharmacology May 1, 2026 Otto Simonsson, Taylor Lyons, Joseph Marks et al.

Previous research suggests that psychedelics may, under certain conditions, decrease authoritarian attitudes, but larger and more rigorously designed studies are needed to confirm these findings. We aimed to examine the effects of psychedelic use on authoritarian attitudes. Using data from three separate studies with different designs and populations, we investigated the relationship between...

The Music for Subanesthetic Infusions of Ketamine randomised clinical trial: ketamine as a psychedelic treatment for highly refractory depression

The British Journal of Psychiatry June 18, 2025 Kyle T. Greenway, Nicolas Garel, Lê-Anh Dinh-Williams et al. 8 citations

Background Ketamine exerts potent but transient antidepressant effects in treatment-resistant depression (TRD). Combinations of ketamine and psychotherapy have attracted interest, but no trial has investigated a psychedelic model of ketamine–psychotherapy for TRD to our knowledge. Aims This secondary analysis of a randomised clinical trial (RCT) explores the therapeutic effects and experiential...

The Role of the Dorsolateral Prefrontal Cortex in Ego Dissolution and Emotional Arousal During the Psychedelic State.

Human Brain Mapping April 1, 2025 Clayton R. Coleman, Kenneth Shinozuka, Robert Tromm et al. 4 citations

Lysergic acid diethylamide (LSD) is a classic serotonergic psychedelic that induces a profoundly altered conscious state. In conjunction with psychological support, it is currently being explored as a treatment for generalized anxiety disorder and depression. The dorsolateral prefrontal cortex (DLPFC) is a brain region that is known to be involved in mood regulation and disorders; hypofunction...

DOI: 10.1002/hbm.70209 (opens in new tab) Full text (opens in new tab) Psychedelics Consciousness Brain-imaging Altered-states

LSD reconfigures the frequency-specific network landscape of the human brain

bioRxiv March 24, 2025 Kenneth Shinozuka, Mattia Rosso, Clayton R. Coleman et al. 3 citations preprint

Abstract Lysergic acid diethylamide (LSD) and other psychedelic substances profoundly alter human consciousness. While several studies have demonstrated changes in brain function and connectivity associated with psychedelics, we still have a limited understanding of how LSD reshapes brain networks operating across different frequency bands. In this study, we applied the recently developed...

Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic

JAMA Network Open December 5, 2024 Anthony L. Back, Timara K Freeman-Young, Ladybird Morgan et al. 37 citations

Importance The psychological morbidity experienced by physicians, advanced practice practitioners (APPs), and nurses from working during the COVID-19 pandemic includes burnout, depression, and posttraumatic stress disorder (PTSD). Objective To investigate whether psilocybin therapy could improve symptoms of depression, burnout, and PTSD in US clinicians who developed these symptoms from...

DOI: 10.1001/jamanetworkopen.2024.49026 (opens in new tab) Psychedelic medicine Healthcare workers Mental health Covid-19 +1

Effects of External Stimulation on Psychedelic State Neurodynamics.

ACS Chemical Neuroscience February 7, 2024 Pedro A. M. Mediano, Fernando E. Rosas, Christopher Timmermann et al. 60 citations

Recent findings have shown that psychedelics reliably enhance brain entropy (understood as neural signal diversity), and this effect has been associated with both acute and long-term psychological outcomes, such as personality changes. These findings are particularly intriguing, given that a decrease of brain entropy is a robust indicator of loss of consciousness (e.g., from wakefulness to...

DOI: 10.1021/acschemneuro.3c00289 (opens in new tab) Full text (opens in new tab) Complexity Consciousness Psychedelics Sensory processing +1

Increased low-frequency brain responses to music after psilocybin therapy for depression.

Journal of Affective Disorders July 15, 2023 Matthew B. Wall, Cynthia Lam, Natalie Ertl et al. 36 citations

Psychedelic-assisted psychotherapy with psilocybin is an emerging therapy with great promise for depression, and modern psychedelic therapy (PT) methods incorporate music as a key element. Music is an effective emotional/hedonic stimulus that could also be useful in assessing changes in emotional responsiveness following PT. Brain responses to music were assessed before and after PT using...

Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression

Journal of Psychopharmacology November 26, 2022 Melissa Shukuroglou, Leor Roseman, David Nutt et al. 38 citations

Background: Music listening is a staple and valued component of psychedelic therapy, and previous work has shown that psychedelics can acutely enhance music-evoked emotion. Aims: The present study sought to examine subjective responses to music before and after psilocybin therapy for treatment-resistant depression, while functional magnetic resonance imaging (fMRI) data was acquired. Methods:...

The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world

Psychopharmacology August 8, 2022 Rosalind Watts, Hannes Kettner, Dana Geerts et al. 159 citations

Abstract Rationale A general feeling of disconnection has been associated with mental and emotional suffering. Improvements to a sense of connectedness to self, others and the wider world have been reported by participants in clinical trials of psychedelic therapy. Such accounts have led us to a definition of the psychological construct of ‘connectedness’ as ‘a state of feeling connected to...

Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.

Journal of Psychopharmacology August 1, 2022 Victoria Amalie Nygart, Lis Marie Pommerencke, Eline Haijen et al. 73 citations

Background: Over the last two decades, a number of studies have highlighted the potential of psychedelic therapy. However, questions remain to what extend these results translate to naturalistic samples, and how contextual factors and the acute psychedelic experience relate to improvements in affective symptoms following psychedelic experiences outside labs/clinics. The present study sought to...

DOI: 10.1177/02698811221101061 (opens in new tab) Full text (opens in new tab) Psychedelic therapy Depression treatment Mental well-being Clinical research +10

Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey.

Psychopharmacology November 4, 2021 Joanna Kuć, Hannes Kettner, Fernando E. Rosas et al. 37 citations

RATIONALE: Classic psychedelics are currently being studied as novel treatments for a range of psychiatric disorders. However, research on how psychedelics interact with other psychoactive substances remains scarce. OBJECTIVES: The current study aimed to explore the subjective effects of psychedelics when used alongside cannabis. METHODS: Participants (n = 321) completed a set of online surveys...

DOI: 10.1007/s00213-021-05999-1 (opens in new tab) Full text (opens in new tab) Psychedelics Cannabis/marijuana/weed Drug interactions Altered states +1

Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample

Frontiers in Psychiatry June 29, 2021 Keri Mans, Hannes Kettner, David Erritzøe et al. 65 citations

In the last 15 years, psychedelic substances, such as LSD and psilocybin, have regained legitimacy in clinical research. In the general population as well as across various psychiatric populations, mental well-being has been found to significantly improve after a psychedelic experience. Mental well-being has large socioeconomic relevance, but it is a complex, multifaceted construct. In this...

DOI: 10.3389/fpsyt.2021.647909 (opens in new tab) Psilocybin Mental health Well-being Clinical psychology +3

Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use

Journal of Medical Internet Research May 4, 2021 Sebastian Hübner, Eline Haijen, Mendel Kaelen et al. 23 citations

Background The resurgence of research and public interest in the positive psychological effects of psychedelics, together with advancements in digital data collection techniques, have brought forth a new type of research design, which involves prospectively gathering large-scale naturalistic data from psychedelic users; that is, before and after the use of a psychedelic compound. A...

DOI: 10.2196/25973 (opens in new tab) Attrition Health psychology Logistic regression Personality +4

Increased sensitivity to strong perturbations in a whole-brain model of LSD.

Neuroimage January 29, 2021 Beatrice M. Jobst, Selen Atasoy, Adrián Ponce-Alvarez et al. 37 citations

Lysergic acid diethylamide (LSD) is a potent psychedelic drug, which has seen a revival in clinical and pharmacological research within recent years. Human neuroimaging studies have shown fundamental changes in brain-wide functional connectivity and an expansion of dynamical brain states, thus raising the question about a mechanistic explanation of the dynamics underlying these alterations....

Neural correlates of the LSD experience revealed by multimodal neuroimaging

UNC Libraries April 22, 2020 Peter J. Hellyer, Luke T. J. Williams, Ben Sessa et al. 1 citation

Lysergic acid diethylamide (LSD), the prototypical “psychedelic,” may be unique among psychoactive substances. In the decades that followed its discovery, the magnitude of its effect on science, the arts, and society was unprecedented. LSD produces profound, sometimes life-changing experiences in microgram doses, making it a particularly powerful scientific tool. Here we sought to examine its...

DOI: 10.17615/et5z-st50 (opens in new tab) Neuroimaging Cognitive psychology Cognition

Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory.

Journal of Psychopharmacology July 11, 2019 Leor Roseman, Eline Haijen, Kelvin Idialu-Ikato et al. 415 citations

Background: Psychedelic therapy is gaining recognition and the nature of the psychedelic experience itself has been found to mediate subsequent long-term psychological changes. Much emphasis has been placed on the occurrence of mystical-type experiences in determining long-term responses to psychedelics yet here we demonstrate the importance of another component, namely: emotional breakthrough....

DOI: 10.1177/0269881119855974 (opens in new tab) Psychedelics Hallucinogens Entheogens Mind-altering substances +16

Predicting Responses to Psychedelics: A Prospective Study

Frontiers in Pharmacology November 2, 2018 Adam Hampshire, Christopher Timmermann, Christopher Timmermann et al. 422 citations

Responses to psychedelics are notoriously difficult to predict, yet significant work is currently underway to assess their therapeutic potential and the level of interest in psychedelics among the general public appears to be increasing. We aimed to collect prospective data in order to improve our ability to predict acute- and longer-term responses to psychedelics. Individuals who planned to...

DOI: 10.3389/fphar.2018.00897 (opens in new tab) Psychedelic outcomes Psychological well-being Predictive factors

Psychedelics and music: neuroscience and therapeutic implications

International Review of Psychiatry July 4, 2018 Frederick S. Barrett, Katrin H. Preller, Mendel Kaelen 85 citations

From the beginning of therapeutic research with psychedelics, music listening has been consistently used as a method to guide or support therapeutic experiences during the acute effects of psychedelic drugs. Recent findings point to the potential of music to support meaning-making, emotionality, and mental imagery after the administration of psychedelics, and suggest that music plays an...

Effects of psilocybin therapy on personality structure

Acta Psychiatrica Scandinavica June 19, 2018 David Erritzøe, Leor Roseman, Matthew M. Nour et al. 268 citations

Objective To explore whether psilocybin with psychological support modulates personality parameters in patients suffering from treatment‐resistant depression (TRD). Method Twenty patients with moderate or severe, unipolar, TRD received oral psilocybin (10 and 25 mg, one week apart) in a supportive setting. Personality was assessed at baseline and at 3‐month follow‐up using the Revised NEO...

DOI: 10.1111/acps.12904 (opens in new tab) Psilocybin Neuroticism Extraversion and introversion Clinical psychology +3

Correction to: The hidden therapist: evidence for a central role of music in psychedelic therapy.

Psychopharmacology May 1, 2018 Mendel Kaelen, Bruna Giribaldi, Jordan Raine et al. 9 citations correction

The article The hidden therapist: evidence for a central role of music in psychedelic therapy, written by Mendel Kaelen, Bruna Giribaldi, Jordan Raine, Lisa Evans, Christopher Timmerman, Natalie Rodriguez, Leor Roseman, Amanda Feilding, David Nutt, Robin Carhart-Harris, was originally published electronically on the publisher's internet portal.

Psychedelics and the essential importance of context.

Journal of Psychopharmacology February 15, 2018 Robin Carhart-Harris, Leor Roseman, Eline Haijen et al. 646 citations

Psychedelic drugs are making waves as modern trials support their therapeutic potential and various media continue to pique public interest. In this opinion piece, we draw attention to a long-recognised component of the psychedelic treatment model, namely ‘set’ and ‘setting’ – subsumed here under the umbrella term ‘context’. We highlight: (a) the pharmacological mechanisms of classic...

DOI: 10.1177/0269881118754710 (opens in new tab) Psychedelics Hallucinogens Entheogens Psychedelic compounds +21

The hidden therapist: evidence for a central role of music in psychedelic therapy

Psychopharmacology February 1, 2018 Mendel Kaelen, Bruna Giribaldi, Jordan Raine et al. 274 citations

Recent studies have supported the safety and efficacy of psychedelic therapy for mood disorders and addiction. Music is considered an important component in the treatment model, but little empirical research has been done to examine the magnitude and nature of its therapeutic role. The present study assessed the influence of music on the acute experience and clinical outcomes of psychedelic...

Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD.

Scientific Reports December 15, 2017 Selen Atasoy, Leor Roseman, Mendel Kaelen et al. 225 citations

Recent studies have started to elucidate the effects of lysergic acid diethylamide (LSD) on the human brain but the underlying dynamics are not yet fully understood. Here we used 'connectome-harmonic decomposition', a novel method to investigate the dynamical changes in brain states. We found that LSD alters the energy and the power of individual harmonic brain states in a frequency-selective...

LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm.

Neuropharmacology November 20, 2017 Christopher Timmermann, Meg J. Spriggs, Mendel Kaelen et al. 83 citations

Under the predictive coding framework, perceptual learning and inference are dependent on the interaction between top-down predictions and bottom-up sensory signals both between and within regions in a network. However, how such feedback and feedforward connections are modulated in the state induced by lysergic acid diethylamide (LSD) is poorly understood. In this study, an auditory oddball...

DOI: 10.1016/j.neuropharm.2017.10.039 (opens in new tab) LSD LSD Neuroscience brain Neural adaptation Brain network dynamics +2

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.

Psychopharmacology November 8, 2017 R. L. Carhart-Harris, Mark Bolstridge, C. M. J. Day et al. 978 citations

RATIONALE: Recent clinical trials are reporting marked improvements in mental health outcomes with psychedelic drug-assisted psychotherapy. OBJECTIVES: Here, we report on safety and efficacy outcomes for up to 6 months in an open-label trial of psilocybin for treatment-resistant depression. METHODS: Twenty patients (six females) with (mostly) severe, unipolar, treatment-resistant major...